29 results on '"Saut, Noemie"'
Search Results
2. GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis
3. F2c.*C20209T mutation in patients with a history of thrombosis: A case report, retrospective 2 site‐results and review of the literature.
4. A Genome Wide Association Study on plasma FV levels identified PLXDC2 as a new modifier of the coagulation process
5. A meta-analysis of genome-wide association studies identifies ORM1 as a novel gene controlling thrombin generation potential
6. Effect of CYP2C19*2 and *17 Genetic Variants on Platelet Response to Clopidogrel and Prasugrel Maintenance Dose and Relation to Bleeding Complications
7. CYP2C19*2 and *17 Alleles Have a Significant Impact on Platelet Response and Bleeding Risk in Patients Treated With Prasugrel After Acute Coronary Syndrome
8. Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors
9. Usefulness of High Clopidogrel Maintenance Dose According to CYP2C19 Genotypes in Clopidogrel Low Responders Undergoing Coronary Stenting for Non ST Elevation Acute Coronary Syndrome
10. C4BPB/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S–independent mechanism: results from genome-wide association and gene expression analyses followed by case-control studies
11. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach
12. Effect of Cytochrome P450 Polymorphisms on Platelet Reactivity After Treatment With Clopidogrel in Acute Coronary Syndrome
13. Polymorphisms of the lamina maturation pathway and their association with the metabolic syndrome: the DESIR prospective study
14. A follow-up study of a genome-wide association scan identifies a susceptibility locus for venous thrombosis on chromosome 6p24.1
15. Role of the T744C polymorphism of the P2Y12 gene on platelet response to a 600-mg loading dose of clopidogrel in 597 patients with non-ST-segment elevation acute coronary syndrome
16. Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors
17. ABO blood group, glycosyltransferase activity and risk of venous thromboembolism
18. ABO blood group, glycosyltransferase activity and risk of Venous Thrombosis
19. Complete deletion of the AZFb interval from the Y chromosome in an oligozoospermic man
20. Common Risk Factors Add to Inherited Thrombophilia to Predict Venous Thromboembolism Risk in Families
21. KNG1 Ile581Thr and susceptibility to venous thrombosis
22. First case of a humanRASGRP2mutation affecting Rap1 activation in platelets and causing severe bleeding.
23. Human CalDAG-GEFI gene (RASGRP2) mutation affects platelet function and causes severe bleeding
24. TAFI antigen level variability in young healthy Asian Indians; First report from Asia
25. Adrenergic receptor polymorphisms and platelet reactivity after treatment with dual antiplatelet therapy with aspirin and clopidogrel in acute coronary syndrome
26. Polymorphisms of the lamina maturation pathway and their association with the metabolic syndrome: the DESIR prospective study
27. Dendritic Cells Permit Identification of Genes Encoding MHC Class II–Restricted Epitopes of Transplantation Antigens
28. Association of vitronectin and plasminogen activator inhibitor-1 levels with the risk of metabolic syndrome and type 2 diabetes mellitus
29. A Multi-stage/multi-design Strategy Identifies a New QTL for VWF on Chromosome 6-a Possible Link with Venous ThromboEmbolism (VTE)?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.